Medical Health & Life Science Research News

New report: Big data investments in healthcare & pharmaceutical industry are expected to be nearly $4 billion by Q4 2017

New Research estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4 Billion in 2017 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of more than 15% over the next three years.

- Advertisement -
- Market Research Pro -

Big Data in the Healthcare & Pharmaceutical Industry: 2017 – 2030 – Opportunities, Challenges, Strategies & Forecasts

Download sample @ marketreportscenter.com/request-sample/551461  

“Big Data” originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyse. However, the scope of the term has significantly expanded over the years.

Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyse large and variable collections of data, to solve complex problems.

Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors.

- Advertisement -
- Market Research Pro -
The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.

Access Full report along with excel sheets @marketreportscenter.com/buy-now?sku=SNSAUG071701

Future Roadmap

We expect the market to evolve considerably between 2017 and 2030, as new use cases emerge with the industry's increasing focus on value-based care, proactive patient monitoring, precision medicine and population health management.

Overview & Investment Potential

Big Data and associated analytics enable a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, ranging from drug discovery and precision medicine to  clinical decision support and population health management.

What will market research report provide?

The “Big Data in the Healthcare & Pharmaceutical Industry: 2017 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2017 through to 2030.

The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 36 use cases, 6 regions and 35 countries.

Access report @ marketreportscenter.com/request-discount/551461  

What Segmentation is covered in report?

Market forecasts are provided for each of the following submarkets and their subcategories:

Hardware, Software & Professional Services

- Hardware

- Software

- Professional Services

Horizontal Submarkets

- Storage & Compute Infrastructure

- Networking Infrastructure

- Hadoop & Infrastructure Software

- SQL

- NoSQL

- Analytic Platforms & Applications

- Cloud Platforms

- Professional Services

Application Areas

- Pharmaceutical & Medical Products

- Core Healthcare Operations

- Healthcare Support, Awareness & Disease Prevention

- Health Insurance & Payer Services

- Marketing, Sales & Other Applications

Use Cases

- Drug Discovery, Design & Development

- Medical Product Design & Development

- Clinical Development & Trials

- Precision Medicine & Genomics

- Manufacturing & Supply Chain Management

- Post-Market Surveillance & Pharmacovigilance

- Medical Product Fault Monitoring

- Clinical Decision Support

- Care Coordination & Delivery Management

- CER (Comparative Effectiveness Research) &

Observational Evidence

- Personalized Healthcare & Targeted Treatments

- Data-Driven Preventive Care & Health Interventions

- Surgical Practice & Complex Medical Procedures

- Pathology, Medical Imaging & Other Medical Tests

- Proactive & Remote Patient Monitoring

- Predictive Maintenance of Medical Equipment

- Pharmacy Services

- Self-Care & Lifestyle Support

- Medication Adherence & Management

- Vaccine Development & Promotion

- Population Health Management

- Connected Health Communities & Medical Knowledge

Dissemination

- Epidemiology & Disease Surveillance

- Health Policy Decision Making

- Controlling Substance Abuse & Addiction

- Increasing Awareness & Accessible Healthcare

- Health Insurance Claims Processing & Management

- Fraud & Abuse Prevention

- Proactive Patient Engagement

- Accountable & Value-Based Care

- Data-Driven Health Insurance Premiums

- Marketing & Sales

- Administrative & Customer Services

- Finance & Risk Management

- Healthcare Data Monetization

- Other Use Cases

Regional Markets

- Asia Pacific

- Eastern Europe

- Latin & Central America

- Middle East & Africa

- North America

- Western Europe

Country Markets

Argentina, Australia, Brazil, Canada, China, Czech

Republic, Denmark, Finland, France, Germany, India, Indonesia, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Norway, Pakistan, Philippines, Poland, Qatar, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, UAE, UK, USA

What are key findings of report?

The report has the following key findings:

 - In 2017, Big Data vendors will pocket nearly $4 Billion from hardware, software and professional services revenues in the healthcare and pharmaceutical industry. These investments are further expected to grow at a CAGR of more than 15% over the next three years, eventually accounting for over $5.8 Billion by the end of 2020.

 - Through the use of Big Data technologies, hospitals and other healthcare facilities have been able to achieve cost reductions of more than 10%, improvements in outcomes by as much as 20% for certain conditions, growth in revenue by 30%, and increase in patient access to services by more than 35%.

 - Big Data technologies are playing a pivotal role in accelerating the transition towards accountable and value-based care models, by enabling the continuous collection, consolidation and analysis of clinical and operational data from healthcare facilities and other available data sources.

 - Addressing privacy and security concerns is necessary in order to fully leverage the benefits of Big Data in the healthcare and pharmaceutical industry. Therefore, it is essential for key stakeholders to make significant investments in data encryption and cybersecurity, in addition to adopting defensible de-identification techniques and implementing strict restrictions on data use.

For more details of report, table of content, sample download marketreportscenter.com/reports/551461/big-data-in-the-healthcare-pharmaceutical-industry-2017-2030-opportunities-challenges-strategies-forecasts

News From

Market Reports Center - One Stop Shop for all market research needsMarket Reports Center
Category: Market Research Publishers and RetailersCompany profile: Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable. Market Reports Center currently has more than 1,20,000 plus titles and 30+ Publishers on our platform and growing consistently. We cover more than 35 industry verticals ...